Insider · CIK 0001782338
SVF Endurance (Cayman) Ltd
owner
Files at VIR (Vir Biotechnology, Inc.). First filing Oct 7, 2025, latest Dec 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 11
$0 bought, $18M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VIR: Vir Biotechnology, Inc.
VIROct 9, 2026 · close 11.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | Vir Biotechnology, Inc. | $1.1M 191,854 shares | -1% | +42% from low-51% from high | |
| 32Weak | Vir Biotechnology, Inc. | $1.2M 189,431 shares | -1% | +49% from low-49% from high | |
| 32Weak | Vir Biotechnology, Inc. | $2.9M 463,774 shares | -3% | +43% from low-51% from high | |
| 18Weak | Vir Biotechnology, Inc. | $160k 24,553 shares | -0% | +50% from low-48% from high | |
| 28Weak | Vir Biotechnology, Inc. | $680k 113,099 shares | -1% | +40% from low-52% from high | |
| 32Weak | Vir Biotechnology, Inc. | $1.8M 298,649 shares | -2% | +43% from low-51% from high | |
| 32Weak | Vir Biotechnology, Inc. | $2.1M 330,210 shares | -2% | +47% from low-50% from high | |
| 12Weak | Vir Biotechnology, Inc. | $180k 29,515 shares | -0% | +42% from low-51% from high | |
| 25Weak | Vir Biotechnology, Inc. | $1.5M 251,360 shares | -2% | +41% from low-52% from high | |
| 25Weak | Vir Biotechnology, Inc. | $3.2M 538,375 shares | -3% | +32% from low-55% from high | |
| 25Weak | Vir Biotechnology, Inc. | $2.9M 524,297 shares | -3% | +34% from low-54% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -191,854 | $5.98 | $1.1M | 13,728,924 | Dec 3, 2025 |
| Nov 26, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -127,938 | $6.39 | $818k | 13,982,271 | Dec 1, 2025 |
| Nov 28, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -61,493 | $6.44 | $396k | 13,920,778 | Dec 1, 2025 |
| Nov 24, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -227,803 | $6.15 | $1.4M | 14,346,180 | Nov 26, 2025 |
| Nov 25, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -235,971 | $6.38 | $1.5M | 14,110,209 | Nov 26, 2025 |
| Oct 28, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -24,453 | $6.50 | $159k | 14,574,083 | Oct 30, 2025 |
| Oct 29, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -100 | $6.49 | $649 | 14,573,983 | Oct 30, 2025 |
| Oct 24, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -46,696 | $5.96 | $278k | 14,664,939 | Oct 28, 2025 |
| Oct 27, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -66,403 | $6.05 | $402k | 14,598,536 | Oct 28, 2025 |
| Oct 22, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -144,266 | $6.15 | $888k | 14,866,018 | Oct 24, 2025 |
| Oct 23, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -154,383 | $5.99 | $925k | 14,711,635 | Oct 24, 2025 |
| Oct 20, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -220,535 | $6.20 | $1.4M | 15,119,959 | Oct 22, 2025 |
| Oct 21, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -109,675 | $6.30 | $691k | 15,010,284 | Oct 22, 2025 |
| Oct 15, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -16,671 | $6.07 | $101k | 15,353,338 | Oct 17, 2025 |
| Oct 16, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -12,844 | $6.10 | $78k | 15,340,494 | Oct 17, 2025 |
| Oct 9, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -249,060 | $6.14 | $1.5M | 15,372,309 | Oct 14, 2025 |
| Oct 10, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -2,300 | $6.08 | $14k | 15,370,009 | Oct 14, 2025 |
| Oct 7, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -72,133 | $5.60 | $404k | 16,087,611 | Oct 9, 2025 |
| Oct 8, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -466,242 | $6.05 | $2.8M | 15,621,369 | Oct 9, 2025 |
| Oct 3, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -450,342 | $5.56 | $2.5M | 16,233,699 | Oct 7, 2025 |
| Oct 6, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -73,955 | $5.69 | $421k | 16,159,744 | Oct 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.